PL-13

• Description :

  PL-13 (Compound P11) is the derivative of Trabectedin. PL-13 can disrupt the function of DNA and induces apoptosis in cancer cells. PL-13 be can be used for the research of cancer[1].

• UNSPSC :

  12352005

• Target :

  ADC Payload; Apoptosis; Drug Derivative

• Related Pathways :

  Antibody-drug Conjugate/ADC Related; Apoptosis; Others

• Field of Research :

  Cancer

• Smiles :

  N#C[C@@H]([C@]1([H])CC2=CC(C)=C3OC)N([C@](CO4)([H])C5=C(OCO6)C6=C7C)[C@@]([C@@](N1C)([H])C2=C3O)([H])[C@@](SC[C@](C8=CC(OC)=C9NC(CN)=O)(NCCC8=C9)C4=O)([H])C5=C7OC(C)=O

• Molecular Formula :

  C42H46N6O10S

• Molecular Weight :

  826.91

• References & Citations :

  [1]Bin Zou, et al. Anti-alpp/alppl2 antibodies, antibody-drug conjugates, and uses thereof. WO2025048716A1. 2025-03-06.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  ADC Related

• Clinical Information :

  No Development Reported

• CAS Number :

  [3056740-00-9]